US FDA announces hike in PDUFA user fee rates for FY 2012
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration is to increase the fee it charges for reviewing drug applications that require clinical data by 19.4% to $1.8 million, the agency revealed in a Federal Register notice of its new prescription drug user fee rates for fiscal year 20121.